Calendar

Date TBD

RECRUITINGphase readoutNCT06149481: Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Metastatic Colorectal Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial

Sponsor: Abiomed Inc.. Phase: NA. Conditions: ST Elevation (STEMI) Myocardial Infarction of Anterior Wall

full page →ctgov ↗

COMPLETEDphase readoutNCT07336030: Effect of Baduanjin Exercise in Diabetic Patients

Sponsor: Cairo University. Phase: NA. Conditions: Diabetes Mellitus

full page →ctgov ↗

RECRUITINGphase readoutNCT06623630: Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function

Sponsor: Washington University School of Medicine. Phase: PHASE1. Conditions: Multiple Myeloma

full page →ctgov ↗

RECRUITINGphase readoutNCT01375530: Screening Volunteers for Clinical Trials

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Screening

full page →ctgov ↗

RECRUITINGphase readoutNCT07457528: Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC

Sponsor: Tianjin Medical University Cancer Institute and Hospital. Phase: PHASE2. Conditions: Resectable Esophageal Squamous Cell Carcinoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07550465: Study of QLS1410 in the Treatment of Primary Aldosteronism.

Sponsor: Qilu Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Primary Aldosteronism

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06682767: A Nutritional Intervention for Body, Brain, and Longevity Effects (NIBBLE)

Sponsor: Cedars-Sinai Medical Center. Phase: NA. Conditions: Cerebral Blood Flow, APOE 4

full page →ctgov ↗

RECRUITINGphase readoutNCT03835767: Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE2. Conditions: Milk and/or Peanut Allergy

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07380867: Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorectal Cancer Surgery.

Sponsor: Seoul St. Mary's Hospital. Phase: NA. Conditions: Colorectal Cancer, Endoscopic Tattoo of Suspected Colon Cancer, Indocyanine Green (ICG)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05852600: Parent-focused Intervention to Reduce HIV Risk in Gay and Bisexual Adolescents

Sponsor: George Washington University. Phase: NA. Conditions: Hiv, Sexual Health

full page →ctgov ↗

COMPLETEDphase readoutNCT05843565: Standard Versus Hyperangulated Video Laryngoscopy Blades for Intubation in Neonates and Small Infants

Sponsor: American University of Beirut Medical Center. Phase: NA. Conditions: Intubation; Difficult or Failed

full page →ctgov ↗

RECRUITINGphase readoutNCT06575400: A Study to Test How Well Different Doses of BI 3804379 Are Tolerated by Healthy People

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗

RECRUITINGphase readoutNCT04526600: Fidgeting and Attentional and Emotional Regulation in ADHD

Sponsor: University of California, Davis. Phase: NA. Conditions: ADHD

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05467800: Study of Canakinumab in Patients With Myelofibrosis

Sponsor: John Mascarenhas. Phase: PHASE2. Conditions: Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF, Post-polycythemia Vera Related Myelofibrosis, PV-MF

full page →ctgov ↗

RECRUITINGphase readoutNCT05168605: Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Hypertension, Type 2 Diabetes

full page →ctgov ↗

COMPLETEDphase readoutNCT07181005: The Validity and Reliability of an Improved Paper Grasping Test for Stroke

Sponsor: Sanko University. Phase: . Conditions: Stroke, Balance, Validity and Safety

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07469241: Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma.

Sponsor: Fudan University. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma, Unresectable Esophageal Squamous Cell Carcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT07168200: A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd. Phase: PHASE3. Conditions: Advanced Cervical Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03301792: Group Versus Traditional Prenatal Care for Diabetes

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Pregnancy, Gestational Diabetes, Type 2 Diabetes

full page →ctgov ↗

RECRUITINGphase readoutNCT07422792: Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients

Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Chronic Intestinal Failure, Intestinal Failure, Home Parenteral Nutrition

full page →ctgov ↗

RECRUITINGphase readoutNCT06582771: A Study of Sotorasib in People With Non-Small Cell Lung Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Non Small Lung Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06961071: Parathyroid Allotransplant for Treatment of Hypoparathyroidism

Sponsor: Peter Stock. Phase: PHASE1. Conditions: Hypoparathyroidism, Hypoparathyroidism Postprocedural, Hypoparathyroidism Post-surgical

full page →ctgov ↗

COMPLETEDphase readoutNCT07318844: Stroke Volume at Rest and During Exercise in Healthy Volunteers

Sponsor: Rigshospitalet, Denmark. Phase: NA. Conditions: Healthy

full page →ctgov ↗

COMPLETEDphase readoutNCT07476664: Acute Oroantral Communication Closure: Resorbable Collagen Membrane vs. Buccal Advancement Flap Outcomes

Sponsor: Medical University of Silesia. Phase: NA. Conditions: Oroantral Communication, Acute Oroantral Communication, Oroantral Fistula, Post-extraction Maxillary Sinus Communication

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07452809: Results Between Robotic-assisted and Manual Total Knee Arthroplasty With Kinematic Alignment

Sponsor: Jakub Błaszczyk. Phase: NA. Conditions: Knee Arthritis, Osteoarthritis

full page →ctgov ↗

COMPLETEDphase readoutNCT04868032: Gaining Optimism After Weight Loss Surgery (GOALS) II

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Bariatric Surgery

full page →ctgov ↗

COMPLETEDphase readoutNCT07508098: Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma

Sponsor: Pak Emirates Military Hospital. Phase: PHASE4. Conditions: Melasma (Facial Melasma)

full page →ctgov ↗

RECRUITINGphase readoutNCT05361798: A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Cancer Of Prostate

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03065387: Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Advanced Malignant Solid Neoplasm, EGFR Gene Amplification, EGFR Gene Mutation, ERBB2 Gene Amplification, ERBB2 Gene Mutation, ERBB3 Gene Mutation, ERBB4 Gene Mutation, KRAS Gene Mutation, Metastatic Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm

full page →ctgov ↗

RECRUITINGphase readoutNCT06555393: Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study

Sponsor: University of Alberta. Phase: PHASE1. Conditions: High Blood Sugar, High Blood Pressure, Overweight and Obesity

full page →ctgov ↗

RECRUITINGphase readoutNCT07440706: Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome

Sponsor: Kaiser Clinic and Hospital. Phase: NA. Conditions: Dumping Syndrome, Post-bariatric Hypoglycemia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07523204: Photobiomodulation Therapy for Scar Quality After Facial Wound Closure

Sponsor: Hani M. Al-Kufi. Phase: NA. Conditions: Traumatic Facial Wounds

full page →ctgov ↗

RECRUITINGphase readoutNCT06024304: InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery

Sponsor: Paul E. Matuszewski. Phase: NA. Conditions: Fracture of Hip

full page →ctgov ↗

COMPLETEDphase readoutNCT05289804: Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment

Sponsor: University of Dublin, Trinity College. Phase: PHASE1. Conditions: Mild Cognitive Impairment, Memory Impairment, Memory Disorders in Old Age

full page →ctgov ↗

COMPLETEDphase readoutNCT05160233: Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care

Sponsor: Kaiser Permanente. Phase: NA. Conditions: Drug Use Disorders, Illicit Drug Use, Alcohol-Related Disorders, Opioid Use Disorder

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06932952: A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors

Sponsor: Byondis B.V.. Phase: PHASE1. Conditions: Solid Tumor

full page →ctgov ↗

COMPLETEDphase readoutNCT07441538: Optimizing the Timing for Facial Surgical Dressing Removal

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: NA. Conditions: Nevus, Seborrheic Keratosis (SK), Cyst, Lipoma, Scar

full page →ctgov ↗

RECRUITINGphase readoutNCT05592938: Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Breast Cancer, Breast Cancer Recurrent

full page →ctgov ↗

COMPLETEDphase readoutNCT03352258: Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease

Sponsor: Valentina Garibotto. Phase: NA. Conditions: Alzheimer Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT04481555: Eosinophil-guided Reduction of Inhaled Corticosteroids

Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark. Phase: PHASE4. Conditions: COPD, Inhaled Corticosteroid, Azithromycin, COPD Exacerbation, Pneumonia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06643455: Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial

Sponsor: Fred Hutchinson Cancer Center. Phase: NA. Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07318155: A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

Sponsor: Sirius Therapeutics Co., Ltd.. Phase: PHASE2. Conditions: Coronary Artery Disease (CAD), Peripheral Arterial Disease

full page →ctgov ↗

COMPLETEDphase readoutNCT03939026: Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

Sponsor: Allogene Therapeutics. Phase: PHASE1. Conditions: Relapsed/Refractory Large B Cell Lymphoma, Relapsed/Refractory Follicular Lymphoma

full page →ctgov ↗

RECRUITINGphase readoutNCT05814055: The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

Sponsor: University of Florida. Phase: PHASE2. Conditions: Smoking

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07381426: Ferric Citrate in Iron Deficiency Anemia During Pregnancy

Sponsor: Dhaka Medical College. Phase: PHASE3. Conditions: Anemia

full page →ctgov ↗

RECRUITINGphase readoutNCT03004326: Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Sponsor: Peter Merkel. Phase: . Conditions: Cryoglobulinemic Vasculitis (CV), Drug-induced Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), IgA Vasculitis, Isolated Cutaneous Vasculitis, Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Urticarial Vasculitis, Vasculitis

full page →ctgov ↗

COMPLETEDphase readoutNCT07410026: Diagnostic and Therapeutic Efficacy and Safety of Enteroscopy in Pediatric Patients

Sponsor: Shandong University. Phase: . Conditions: Small Bowel Diseases

full page →ctgov ↗

RECRUITINGphase readoutNCT07519915: Improvement of Understanding of Pediatric Sacral Neuromodulation: Therapeutic Strategies and Outcome Variables

Sponsor: Friedrich-Alexander-Universität Erlangen-Nürnberg. Phase: NA. Conditions: Gastrointestinal Motility Disorders in Children, Hirschsprung Disease, Constipation - Functional

full page →ctgov ↗

RECRUITINGphase readoutNCT00231400: Pompe Disease Registry Protocol

Sponsor: Genzyme, a Sanofi Company. Phase: . Conditions: Glycogen Storage Disease Type II, Pompe Disease

full page →ctgov ↗

← prev

page 5 of 75

Date TBD